AFTX-201

N/A

Report date: 2026/04/08 16:23:46

Base Information

Drug NameAFTX-201
Drug Alias NameAFTX-201
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Adeno-associated virus vector
Mechanisms of ActionBAG3 gene transference
TargetsBAG family molecular chaperone regulator 3
Therapy Area/IndicationsCardiomyopathy, Dilated
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAffinia Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAffinia Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsCardiomyopathy, Dilated
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A